遗传 ›› 2026, Vol. 48 ›› Issue (11): 1085-1097.doi: 10.16288/j.yczz.26-145

• 研究报告 • 上一篇    下一篇

七鳃鳗NATTERIN通过调控心脏脂质转运与代谢改善高脂血症的机制研究

杜泽宇1,2(), 孙世禧1,2, 邱昱颉1,2, 逄越1,2()   

  1. 1 辽宁师范大学生命科学学院, 大连 116081
    2 辽宁师范大学七鳃鳗研究中心, 大连 116081
  • 收稿日期:2026-06-16 修回日期:2026-10-13 出版日期:2026-11-20 发布日期:2026-10-23
  • 通讯作者: 逄越,博士,教授,研究方向:七鳃鳗比较免疫起源与演化。E-mail: pangyue01@163.com
  • 作者简介:杜泽宇,博士,讲师,研究方向:七鳃鳗比较基因组。E-mail: duzeyu@lnnu.edu.cn
  • 基金资助:
    国家自然科学基金项目(32070518);国家自然科学基金项目(32470558);辽宁省科技厅应用基础项目(XLYC2002093);辽宁省教育厅项目(JTYQN2023268);辽宁省教育厅项目(JYTMS20231060);大连市青年科技之星项目(2022RQ041)

Mechanistic study on the role of lamprey NATTERIN in ameliorating hyperlipidemia by regulating cardiac lipid transport and metabolism

Zeyu Du1,2(), Shixi Sun1,2, Yujie Qiu1,2, Yue Pang1,2()   

  1. 1 College of Life Science, Liaoning Normal University, Dalian 116081, China
    2 Lamprey Research Center, Liaoning Normal University, Dalian 116081, China
  • Received:2026-06-16 Revised:2026-10-13 Published:2026-11-20 Online:2026-10-23
  • Supported by:
    National Natural Science Foundation of China(32070518);National Natural Science Foundation of China(32470558);Applied Basic Research Project of the Science and Technology Department of Liaoning Province(XLYC2002093);Project of the Educational Department of Liaoning Province(JTYQN2023268);Project of the Educational Department of Liaoning Province(JYTMS20231060);Dalian Youth Science and Technology Star Fund Project(2022RQ041)

摘要:

高脂血症是诱发心血管疾病的重要危险因素之一。七鳃鳗作为现存无颌类脊椎动物,保留了脊椎动物原始祖先脂肪代谢特征的独特生理体系。为探究该体系中是否存在可用于高脂血症治疗的新型降脂活性分子,本研究首先通过多组织转录组比较分析,筛选获得七鳃鳗心脏特异性表达基因集合,其中NATTERIN可被肾上腺素诱导上调。利用过表达NATTERIN的转基因斑马鱼模型证实,NATTERIN可促进心脏脂质富集及外周血管内脂质减少;转录组分析显示,心脏脂质转运与代谢相关基因FABP3、PPARα、PGC1α等显著上调。相反, siRNA介导NATTERIN沉默的七鳃鳗胚胎中,脂肪酸代谢通路明显被抑制,PPARα和PGC1α的表达水平下调。进一步利用四丁酚醛构建雷氏七鳃鳗(Lethenteron reissneri)急性高脂血症模型,经重组NATTERIN蛋白干预后,血浆甘油三酯、总胆固醇及低密度脂蛋白胆固醇水平显著下降,高密度脂蛋白胆固醇水平升高;同时,心脏组织中PPARα、PGC1α等脂肪酸代谢相关基因表达上调,游离脂肪酸含量恢复至正常水平。综上,七鳃鳗NATTERIN通过激活心脏FABP3、PGC1α和PPARα等脂质转运与代谢相关基因的表达,增强脂肪酸转运和分解代谢能力,促进心脏清除外周血管脂质,为高脂血症的治疗提供基于演化生物学视角的新策略。

关键词: 七鳃鳗, NATTERIN, 心脏, 脂肪酸代谢, 高脂血症

Abstract:

Hyperlipidemia is a major risk factor for cardiovascular diseases. As an extant jawless vertebrate, lampreys possess a unique physiological system that reflects the ancestral features of lipid metabolism in vertebrates. To explore whether this system harbors novel lipid-lowering bioactive molecules applicable to the treatment of hyperlipidemia, we first performed a multi-tissue comparative transcriptomic analysis and identified a set of heart-specific genes in the lamprey, among which NATTERIN was found to be upregulated in response to adrenaline. Using a transgenic zebrafish model overexpressing NATTERIN, we observed that NATTERIN promoted cardiac lipid enrichment and reduced lipid accumulation in peripheral blood vessels. Transcriptomic analysis further revealed significant upregulation of lipid transport- and metabolism-related genes, including the cardiac-type fatty acid-binding protein FABP3, as well as PPARα and PGC1α. Conversely, in lamprey embryos in which NATTERIN was silenced by siRNA, the fatty acid metabolic pathway was markedly suppressed, with reduced expression of PPARα and PGC1α. Furthermore, an acute hyperlipidemia model was established in Lethenteron reissneri using Tyloxapol. Following treatment with recombinant NATTERIN protein, plasma levels of triglycerides, total cholesterol, and low-density lipoprotein cholesterol were significantly decreased, while those of high-density lipoprotein cholesterol were elevated. Concurrently, the expression of PPARα, PGC1α, and other fatty acid metabolism-related genes was upregulated in the heart, with free fatty acid content returning to normal levels. Collectively, these findings demonstrate that NATTERIN activates the expression of cardiac lipid transport and metabolism genes, including FABP3, PGC1α, and PPARα, thereby enhancing fatty acid catabolism and promoting the clearance of lipids from peripheral blood vessels by the heart, and provide an evolutionary perspective for the development of new therapeutic strategies against hyperlipidemia.

Key words: lamprey, NATTERIN, heart, fatty acid metabolism, hyperlipidemia